Free Trial

Banco Bilbao Vizcaya Argentaria S.A. Acquires Shares of 30,000 Liquidia Technologies, Inc. $LQDA

Liquidia Technologies logo with Medical background

Key Points

  • Banco Bilbao Vizcaya Argentaria S.A. has acquired a new position in Liquidia Technologies, purchasing 30,000 shares valued at approximately $463,000 in the first quarter.
  • Insider trading activity shows significant sales, with General Counsel Russell Schundler selling 7,836 shares, representing a 1.34% decrease in his holdings.
  • Liquidia Technologies reported a **141.5% increase** in quarterly revenue compared to the previous year, although it missed earnings expectations with a loss of ($0.49) EPS.
  • Want stock alerts on Liquidia Technologies? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Banco Bilbao Vizcaya Argentaria S.A. bought a new position in Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 30,000 shares of the company's stock, valued at approximately $463,000.

Other large investors have also modified their holdings of the company. Hurley Capital LLC acquired a new position in Liquidia Technologies during the 1st quarter worth approximately $32,000. GAMMA Investing LLC raised its stake in shares of Liquidia Technologies by 65.6% during the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the period. D. E. Shaw & Co. Inc. acquired a new position in shares of Liquidia Technologies during the fourth quarter worth $142,000. Aigen Investment Management LP purchased a new position in shares of Liquidia Technologies in the first quarter valued at $151,000. Finally, Bayesian Capital Management LP acquired a new stake in Liquidia Technologies during the 4th quarter valued at $163,000. Institutional investors and hedge funds own 64.54% of the company's stock.

Insider Buying and Selling

In other news, General Counsel Russell Schundler sold 7,836 shares of Liquidia Technologies stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $14.28, for a total value of $111,898.08. Following the completion of the transaction, the general counsel directly owned 577,977 shares of the company's stock, valued at approximately $8,253,511.56. The trade was a 1.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Rajeev Saggar sold 5,327 shares of the stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $76,069.56. Following the sale, the insider owned 271,413 shares in the company, valued at approximately $3,875,777.64. This trade represents a 1.92% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 90,277 shares of company stock worth $1,469,392. Company insiders own 26.50% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Scotiabank increased their price target on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Raymond James Financial lifted their price objective on Liquidia Technologies from $33.00 to $41.00 and gave the stock a "strong-buy" rating in a report on Wednesday, August 13th. HC Wainwright increased their target price on Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a research note on Wednesday, May 28th. Finally, Jefferies Financial Group began coverage on shares of Liquidia Technologies in a research note on Friday, August 15th. They issued a "buy" rating and a $43.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $32.11.

Get Our Latest Stock Analysis on LQDA

Liquidia Technologies Price Performance

Shares of LQDA opened at $26.84 on Friday. Liquidia Technologies, Inc. has a 52 week low of $8.75 and a 52 week high of $28.00. The company has a current ratio of 2.49, a quick ratio of 2.41 and a debt-to-equity ratio of 9.84. The firm has a market cap of $2.31 billion, a price-to-earnings ratio of -15.79 and a beta of 0.14. The stock has a 50 day moving average of $17.51 and a 200-day moving average of $15.96.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($0.06). The firm had revenue of $8.84 million for the quarter, compared to the consensus estimate of $3.90 million. Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The business's revenue was up 141.5% compared to the same quarter last year. As a group, analysts forecast that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Liquidia Technologies Profile

(Free Report)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Featured Stories

Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report).

Institutional Ownership by Quarter for Liquidia Technologies (NASDAQ:LQDA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Liquidia Technologies Right Now?

Before you consider Liquidia Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia Technologies wasn't on the list.

While Liquidia Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines